885 related articles for article (PubMed ID: 12579570)
41. [Preparation of functional chitosan thermosensitive hydrogel for slow release both rhBMP-2 and chlorhexidine].
Ma ZW; Wang R; Wu ZF; Chen D; Zhang BL; He W; Wang XJ; Liu Q; Xu J; Zhu H
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1049-54. PubMed ID: 18257235
[TBL] [Abstract][Full Text] [Related]
42. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol.
Gabler C; Plath-Gabler A; Killian GJ; Berisha B; Schams D
Reprod Domest Anim; 2004 Oct; 39(5):321-7. PubMed ID: 15367264
[TBL] [Abstract][Full Text] [Related]
43. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
Nakamura S; Kanatani Y; Kishimoto S; Nakamura S; Ohno C; Horio T; Masanori F; Hattori H; Tanaka Y; Kiyosawa T; Maehara T; Ishihara M
J Biomed Mater Res A; 2009 Dec; 91(3):814-23. PubMed ID: 19051304
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor beta-3 bound with sulfate polysaccharide in synthetic extracellular matrix enhanced the biological activities for neocartilage formation in vivo.
Park JS; Woo DG; Yang HN; Na K; Park KH
J Biomed Mater Res A; 2009 Nov; 91(2):408-15. PubMed ID: 18985789
[TBL] [Abstract][Full Text] [Related]
45. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds.
Andreopoulos FM; Persaud I
Biomaterials; 2006 Apr; 27(11):2468-76. PubMed ID: 16321436
[TBL] [Abstract][Full Text] [Related]
46. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.
Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM
Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2).
Liu LS; Ng CK; Thompson AY; Poser JW; Spiro RC
J Biomed Mater Res; 2002 Oct; 62(1):128-35. PubMed ID: 12124794
[TBL] [Abstract][Full Text] [Related]
48. Silicate cross-linked bio-nanocomposite hydrogels from PEO and chitosan.
Jin Q; Schexnailder P; Gaharwar AK; Schmidt G
Macromol Biosci; 2009 Oct; 9(10):1028-35. PubMed ID: 19593783
[TBL] [Abstract][Full Text] [Related]
49. Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules.
Tae G; Kim YJ; Choi WI; Kim M; Stayton PS; Hoffman AS
Biomacromolecules; 2007 Jun; 8(6):1979-86. PubMed ID: 17511500
[TBL] [Abstract][Full Text] [Related]
50. Photocrosslinked bovine serum albumin hydrogels with partial retention of esterase activity.
Abbate V; Kong X; Bansal SS
Enzyme Microb Technol; 2012 Feb; 50(2):130-6. PubMed ID: 22226199
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, characterization and cytotoxicity of photo-crosslinked maleic chitosan-polyethylene glycol diacrylate hybrid hydrogels.
Zhong C; Wu J; Reinhart-King CA; Chu CC
Acta Biomater; 2010 Oct; 6(10):3908-18. PubMed ID: 20416406
[TBL] [Abstract][Full Text] [Related]
52. Biodegradable and pH-sensitive hydrogels for cell encapsulation and controlled drug release.
Wu DQ; Sun YX; Xu XD; Cheng SX; Zhang XZ; Zhuo RX
Biomacromolecules; 2008 Apr; 9(4):1155-62. PubMed ID: 18307310
[TBL] [Abstract][Full Text] [Related]
53. Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels.
McGonigle JS; Tae G; Stayton PS; Hoffman AS; Scatena M
J Biomater Sci Polym Ed; 2008; 19(8):1021-34. PubMed ID: 18644228
[TBL] [Abstract][Full Text] [Related]
54. Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation.
Hong Y; Song H; Gong Y; Mao Z; Gao C; Shen J
Acta Biomater; 2007 Jan; 3(1):23-31. PubMed ID: 16956800
[TBL] [Abstract][Full Text] [Related]
55. Fabrication of poly(ethylene glycol) hydrogel micropatterns with osteoinductive growth factors and evaluation of the effects on osteoblast activity and function.
Subramani K; Birch MA
Biomed Mater; 2006 Sep; 1(3):144-54. PubMed ID: 18458396
[TBL] [Abstract][Full Text] [Related]
56. Photo-cross-linkable and thermo-responsive hydrogels containing chitosan and Pluronic for sustained release of human growth hormone (hGH).
Yoo HS
J Biomater Sci Polym Ed; 2007; 18(11):1429-41. PubMed ID: 17961325
[TBL] [Abstract][Full Text] [Related]
57. Injectable chitosan hydrogels for localised cancer therapy.
Ta HT; Dass CR; Dunstan DE
J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
[TBL] [Abstract][Full Text] [Related]
58. Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1.
Minter AJ; Keoshkerian E; Chesterman CN; Dawes J
J Cell Physiol; 1996 May; 167(2):229-37. PubMed ID: 8613463
[TBL] [Abstract][Full Text] [Related]
59. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
60. Swelling and mechanical properties of biopolymer hydrogels containing chitosan and bovine serum albumin.
Butler MF; Clark AH; Adams S
Biomacromolecules; 2006 Nov; 7(11):2961-70. PubMed ID: 17096520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
